FDA Approves Zilxi (minocycline) Topical Foam for the Treatment of Rosacea

BRIDGEWATER, N.J., May 29, 2020 (GLOBE NEWSWIRE) -- Menlo Therapeutics Inc. (Nasdaq: MNLO) (“Menlo” or the“Company”), a specialty pharmaceutical company focused on developing and commercializing proprietary therapies to...
Source: Drugs.com - New Drug Approvals - Category: Drugs & Pharmacology Source Type: news